[Form 4] Cencora, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Cencora, Inc. reported an insider stock transaction by President & CEO and director Robert P. Mauch. On 12/18/2025, he exercised a non-qualified stock option to acquire 3,763 shares of common stock at an exercise price of $86.09 per share, increasing his directly held common stock before the sale to 73,155 shares. On the same date, he reported a sale of 5,096 shares of common stock at a reported price of $343.45 per share. After these transactions, he directly beneficially owned 68,059 shares of Cencora common stock and 7,525 non-qualified stock options. The option exercised was originally scheduled to vest in four equal installments on 11/13/2020, 11/13/2021, 11/13/2022 and 11/13/2023.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mauch Robert P.

(Last) (First) (Middle)

1 WEST FIRST AVENUE

(Street)

CONSHOHOCKEN PA 19428

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cencora, Inc. [ COR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
12/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/18/2025		M		3,763	A	$86.09	73,155	D
Common Stock	12/18/2025		S		5,096	D	$343.45	68,059	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-qualified Stock Option (Right to Buy)	$86.09	12/18/2025		M			3,763	(1)	11/13/2026	Common Stock	3,763	$0	7,525	D

Explanation of Responses:

1. Exercisable in four equal installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23.

Remarks:

	/s/ Elizabeth S. Campbell, attorney-in-fact for Robert P. Mauch	12/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Cencora (COR) disclose for Robert P. Mauch?

The company disclosed that President & CEO and director Robert P. Mauch exercised a non-qualified stock option for 3,763 shares of Cencora common stock and sold 5,096 shares of common stock on 12/18/2025.

How many Cencora (COR) shares did Robert P. Mauch sell on December 18, 2025?

On 12/18/2025, Robert P. Mauch reported a sale of 5,096 shares of Cencora common stock at a reported price of $343.45 per share.

How many Cencora (COR) stock options did Robert P. Mauch exercise?

He exercised a non-qualified stock option covering 3,763 shares of Cencora common stock at an exercise price of $86.09 per share on 12/18/2025.

What is Robert P. Mauchs Cencora (COR) share ownership after the reported transactions?

Following the reported transactions, Robert P. Mauch directly beneficially owned 68,059 shares of Cencora common stock.

How many Cencora (COR) stock options does Robert P. Mauch still hold after the exercise?

After exercising 3,763 options, Robert P. Mauch reported holding 7,525 non-qualified stock options, each representing the right to buy one share of Cencora common stock.

What role does Robert P. Mauch hold at Cencora (COR)?

Robert P. Mauch is reported as both a director and an officer of Cencora, serving as President & CEO.

When did the exercised Cencora (COR) stock options originally become exercisable?

The non-qualified stock option exercised on 12/18/2025 was scheduled to become exercisable in four equal installments on 11/13/2020, 11/13/2021, 11/13/2022 and 11/13/2023.